Question 1

How many shares of KRYS does Skandinaviska Enskilda Banken AB (publ) own?

Accepted Answer

Skandinaviska Enskilda Banken AB (publ) previously held 0 shares of KRYS (Krystal Biotech, Inc.) before exiting the position in 2026-Q1.

Question 2

What is Skandinaviska Enskilda Banken AB (publ)'s KRYS position worth?

Accepted Answer

Skandinaviska Enskilda Banken AB (publ)'s KRYS position was last reported at $0 in 2026-Q1 before the exit.

Question 3

Is Skandinaviska Enskilda Banken AB (publ) buying or selling KRYS?

Accepted Answer

In 2026-Q1, Skandinaviska Enskilda Banken AB (publ) exited their KRYS position entirely (-100.0% change in shares).

Question 4

When did Skandinaviska Enskilda Banken AB (publ) first buy KRYS?

Accepted Answer

Based on available 13F filings, Skandinaviska Enskilda Banken AB (publ) first reported a position in KRYS in 2024-Q3. They have held the position across 21 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$263.80
2025-Q4	Decreased	46,732	-22.1%	$11.5M	0.0%	$247.88
2025-Q3	Unchanged	59,978	0.0%	$10.6M	0.0%	$176.75
2025-Q2	Unchanged	59,978	0.0%	$8.2M	0.0%	$138.88
2025-Q1	Decreased	59,978	-32.6%	$10.8M	0.1%	$183.92
2024-Q4	Decreased	89,047	-29.4%	$14.2M	0.1%	$159.80
2024-Q3	Decreased	126,082	-34.2%	$23M	0.1%	$177.14